Abstract: A device includes a first buried layer over a substrate, a second buried layer over the first buried layer, a first well over the first buried layer and the second buried layer, a first high voltage well, a second high voltage well and a third high voltage well extending through the first well, wherein the second high voltage well is between the first high voltage well and the third high voltage well, a first drain/source region in the first high voltage well, a first gate electrode over the first well, a second drain/source region in the second high voltage well and a first isolation region in the second high voltage well, and between the second drain/source region and the first gate electrode, wherein a bottom of the first isolation region is lower than a bottom of the second drain/source region.

Abstract: An augmented reality-assisted method for performing surgery comprises: disposing a position sensing element at a facial positioning point of a patient before craniotomy to obtain skull space and intracranial space information for defining a coordinate space; obtaining a brain anatomical image for constructing a three-dimensional graphic, the graphic comprising a graphic positioning point and a feature associated with a gyrus feature; defining a relative positional relationship between the graphic and the space, aligning the facial positioning point with the graphic positioning point; using a probe to obtain a spatial position of the gyrus feature after craniotomy, using the gyrus feature as a calibration reference point; generating a displacement and rotation parameter based on a coordinate difference of the feature relative to the reference point; adjusting a position and/or an angle of the graphic on a display according to the parameter, and the display displaying the calibrated three-dimensional graphic.

Abstract: The present invention provides a medical image processing method, which comprises following steps of: receiving a three-dimensional model image file and at least one medical record data by a medical image processing device; creating a three-dimensional medical file based on the three-dimensional model image file and the at least one medical record data, wherein the three-dimensional medical file conforms to a digital imaging and communications in medicine standard; transmitting the three-dimensional medical file to a medical picture archiving and communication system; retrieving the three-dimensional medical file from the medical picture archiving and communication system by a three-dimensional medical image browsing device which is a non-workstation computer device loaded with a viewer software; and displaying the three-dimensional medical file.

Abstract: A new class of sesquiterpene derivative useful for treating cancerous and inflammatory diseases are disclosed. These deoxyelephantopin derivatives are effective in suppressing proliferation, migration, mobility, invasion, growth, and/or metastasis of cancer cells in a patient, or useful for enhancing an anti-proliferative effect of another anti-cancer drug on cancer cells when treating a patient, or for sensitizing and/or enhancing an anti-cancer effect of a gluthathione synthesis blocker on inhibition of triple negative breast cancer cell activity, or for treatment and/or prophylaxis of lipopolysaccharide-stimulated inflammatory response in a patient, or for all of the above. Also disclosed are methods of preparing the deoxyelephantopin derivatives.

Abstract: A new class of sesquiterpene derivative useful for treating cancerous and inflammatory diseases are disclosed. These deoxyelephantopin derivatives are effective in suppressing proliferation, migration, mobility, invasion, growth, and/or metastasis of cancer cells in a patient, or useful for enhancing an anti-proliferative effect of another anti-cancer drug on cancer cells when treating a patient, or for sensitizing and/or enhancing an anti-cancer effect of a gluthathione synthesis blocker on inhibition of triple negative breast cancer cell activity, or for treatment and/or prophylaxis of lipopolysaccharide-stimulated inflammatory response in a patient, or for all of the above. Also disclosed are methods of preparing the deoxyelephantopin derivatives.